CATALOGO DEI PRODOTTI DELLA RICERCA

SACERDOTI, David
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.981
NA - Nord America 4.619
EU - Europa 4.004
SA - Sud America 523
AF - Africa 62
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 14.215
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.532
SG - Singapore 2.447
CN - Cina 1.265
GB - Regno Unito 902
RU - Federazione Russa 725
FR - Francia 565
HK - Hong Kong 561
IE - Irlanda 534
BR - Brasile 464
KR - Corea 291
UA - Ucraina 271
DE - Germania 257
SE - Svezia 237
IT - Italia 222
VN - Vietnam 182
FI - Finlandia 142
ID - Indonesia 68
CA - Canada 48
AT - Austria 31
IN - India 26
MX - Messico 24
TG - Togo 22
NL - Olanda 21
TR - Turchia 21
AU - Australia 19
BD - Bangladesh 19
BE - Belgio 18
JP - Giappone 17
PL - Polonia 16
AR - Argentina 15
ES - Italia 15
EC - Ecuador 13
ZA - Sudafrica 12
PK - Pakistan 11
CO - Colombia 8
IQ - Iraq 8
VE - Venezuela 8
LT - Lituania 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
NP - Nepal 6
RO - Romania 6
AZ - Azerbaigian 5
CZ - Repubblica Ceca 4
EG - Egitto 4
JO - Giordania 4
MY - Malesia 4
NO - Norvegia 4
SA - Arabia Saudita 4
TN - Tunisia 4
UZ - Uzbekistan 4
AL - Albania 3
CH - Svizzera 3
HN - Honduras 3
HU - Ungheria 3
IL - Israele 3
IR - Iran 3
KE - Kenya 3
KG - Kirghizistan 3
MA - Marocco 3
MD - Moldavia 3
PE - Perù 3
PY - Paraguay 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BO - Bolivia 2
CR - Costa Rica 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
JM - Giamaica 2
KW - Kuwait 2
KZ - Kazakistan 2
MK - Macedonia 2
NG - Nigeria 2
PH - Filippine 2
PS - Palestinian Territory 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
BZ - Belize 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
GT - Guatemala 1
HR - Croazia 1
Totale 14.200
Salva come PNG Salva come JPEG
Città #
Singapore 1.069
Southend 844
Jacksonville 788
Dallas 558
Hong Kong 555
Chandler 548
Dublin 532
Ashburn 401
Lawrence 262
Princeton 262
Beijing 228
Wilmington 220
Jinan 120
Munich 105
Helsinki 98
Ann Arbor 80
Shenyang 80
Dong Ket 79
Jakarta 59
Sindelfingen 59
Nanjing 52
Ningbo 51
Tianjin 47
Changsha 46
Santa Clara 42
São Paulo 42
Haikou 41
Hebei 41
Ho Chi Minh City 41
Los Angeles 41
New York 41
Columbus 38
San Francisco 38
Hangzhou 37
Verona 37
Milan 35
Seattle 34
Zhengzhou 34
Taizhou 32
Fairfield 30
Nanchang 30
Guangzhou 29
Nuremberg 29
Houston 28
Taiyuan 25
Brooklyn 24
Norwalk 24
Redwood City 23
Turku 23
Hanoi 22
Lomé 22
Lanzhou 21
Washington 21
Boston 18
Brussels 18
Toronto 17
Council Bluffs 16
Tokyo 16
Redmond 15
The Dalles 15
Vienna 15
Warsaw 15
Jiaxing 14
London 14
San Diego 14
Chicago 13
Woodbridge 13
Fuzhou 12
Lappeenranta 12
Romola 12
Stockholm 12
Charlotte 11
Mexico City 11
Rio de Janeiro 11
Frankfurt am Main 10
Moscow 10
Phoenix 10
Rome 10
Amsterdam 9
Atlanta 9
Belo Horizonte 9
Boardman 9
Bonndorf 9
Brasília 9
Curitiba 9
Falkenstein 9
Legnago 9
Montreal 9
Des Moines 8
Johannesburg 8
Melbourne 8
Goiânia 7
Sorocaba 7
Brescia 6
Canberra 6
Chennai 6
Manchester 6
Porto Alegre 6
Recife 6
Cordova 5
Totale 8.571
Salva come PNG Salva come JPEG
Nome #
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 180
ALTERAZIONI DEI PARAMETRI ECO-COLOR-DOPPLER SPLANCNICI DI IPERTENSIONE PORTALE NELLA CIRROSI BILIARE PRIMITIVA E NELLA COLANGITE SCLEROSANTE: CONFRONTO CON LA CIRROSI POST-EPATICA E ALCOLICA 132
11,12-EET increases porto-sinusoidal resistance and may play a role in endothelial dysfunction of portal hypertension 128
11,12-Epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells 122
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy 112
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 105
A Pig Model of Hemivascular Liver Occlusion for The Study of Ischemia-Reperfusion Injury: Use of an Infrared System for Detecting Ischemic Areas 89
Effetti della ciclosporina sulla funzione renale e sul metabolismo renale citocromo P450-dipendente dell'acido arachidonico. 81
Alterazioni circolatorie splancniche e periferiche nella cirosi: studio mediante eco-color-doppler. Risultati a lungo termine del Centro Trapianti di Padova. 80
I betabloccanti nel trattamento dell'ipertensione portale in corso di cirrosi epatica. Rapporti tra effetto sulla pressione portale e prevenzione della recidiva emorragica. 79
Accuracy and predictive value of echo-Doppler measurements in acute liver rejection -- initial experience 78
Arterioportal fistulas in patients with liver cirrhosis: Usefulness of color-Doppler US for screening 78
Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis 77
Comparison of computer psychometric tests (CPTs) and number connection test (NCT) in the detection of subclinical hepatic encephalophaty (SHE). 76
Magnesium deficiency (MD) in liver cirrhosis evaluated by intravenous load 76
Alterations in thyroid Doppler arterial resistance indices, volume and hormones in cirrhosis: Relationships with splanchnic haemodynamics 75
Hepatic vein catheterization in the prognostic evaluation in cirrhotics with esophageal varices 75
Effects of direct-acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real-life Italian experience 74
Effetti del nadololo sull'emodinamica e sulla funzione renale, sul sistema renina-angiotensina-aldosterone e sulla produzione renale di PGE2 nei pazienti con cirrosi epatica ed ipertensione portale. 74
Splenic Doppler impedance indeces: influence of different portal hemodynamic conditions. 74
Resistance to spironolactone in nonazotemic ascitic cirrhotic: role of enhanced proximal sodium reabsorption 73
Variability of atrial natriuretic peptide plasma levels in ascitic chirrotics; pathophysiological and clinical implications 71
Assessment of intrarenal sodium handling by lithium clearance in cirrhotic patients with ascites 71
A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care ap¬proach to the diuretic treatment of ascites in non-azotemic cirrhotics 71
Aumento degli indici di resistenza arteriosa epatica nella cirrosi con e senza trombosi portale: rapporti con l'ipertensione portale. 70
Ankle-Brachial Index and cardiovascular events in atrial fibrillation: The ARAPACIS study 69
Confronto tra Captopril e Nifedipina per via sublinguale nel trattamento delle emergenze ipertensive. 68
Heme-oxygenase-1 Induction Improves Type-1 Cardiorenal Syndrome Only In Mice With Impaired AngII-induced Lymphocyte Activation (SCID Mice) 68
Urinary excretion of P450-Hetes: increase of 20-Hete in patients with cirrhosis 68
Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography 67
Alteration in endothelial function in cirrhosis 67
Q-T interval prolongation in liver cirrhosis - Reversibility after orthotopic liver transplantation 67
Arteroportal fistulas between the accessory right hepatic, gastroduodenal and superior mesenteric arteries and portal vein: a difficult technical problem to overcome in liver transplantation 67
Role of prostaglandins in the response to diuretic treatment of ascites in cirrhotic patients. 66
Differential effects of cyclosporine A on hepatic and renal cytocrome P450 dependent metabolism of arachidonic acid. 66
Atrial natriuretic peptide (hANP) plasma levels in ascitic cirrhotics; a better selection of patients is needed ? 66
Arachidonic acid metabolites and endothelial dysfunction of portal hypertension 66
Role of prostaglandins in the response to diuretic treatment of ascites in cirrhotic patients. 66
Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation 66
La vasocostrizione renale in corso di cirrosi epatica: studio mediante eco-color doppler 65
Vasocostrizione renale in corso di cirrosi epatica: studio mediante eco-color doppler. 65
A CO-releaseng molecule, CORM-3, attenuates ischemia/reperfusion incurie in a new model in pig liver 65
Evaluation angiografique semiquantitative de la perfusion portale chez les cirrhotiques: relations avec le debit plasmatique hepatiqhe.[lettre] 65
Subclinical and clinical atherosclerosis in Non-alcoholic Fatty Liver Disease is associated with the presence of hypertension 64
Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy 64
T Regulatory Lymphocytes Function Increased, by Induction Of Ho-1, Improves Type-1 Cardio-Renal Syndrome 64
Differential effects of cyclosporine A on hepatic and renal cytocrom P450 dependent metabolism of arachidonic acid. 64
Interleukin-6: A New Marker of Advanced-Sarcopenic HCC Cirrhotic Patients 63
Renal cytochrome P450-dependent metabolism of arachidonic acid in experimental liver cirrhosis 63
Alterazioni epatiche in corso di scompenso cardiaco 62
Effect of a dietary integration with BCAA or casein on nutritional state and lower limb amino acid exchange in cirrhosis 62
Metabolic-associated fatty liver disease and liver fibrosis scores as COVID-19 outcome predictors: a machine-learning application 61
Renal function in congestive heart failure. 61
HEPATIC VEINS DOPPLER PROFILE MODIFICATIONS DURING ACUTE PORTAL PRESSURE INCREASE INDUCED BY PARAUMBILICAL VEIN COMPRESSION 61
Relationship between renal prostaglandins and renal response to maximal water load in non ascitic liver cirrhosis. 60
Role of prostaglandins in the response to diuretic treatment of ascites in cirrhotic patients. 60
Urinary excretion of P450-Hetes: increase of 20-Hete in patients with cirrhosis 60
Drugs in the prevention of rebleeding in cirrhosis 60
Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis 60
Effetti del defribotide sulla funzione renale in ratti trattati conciclosporina 59
Effects of cyclosporine on renal function and cytochrome P450 -dependent metabolites of arachidonic acid metabolism 59
Left ventricular diastolic function in liver cirrhosis 59
Hepatic vein catheterization in the prognostic evaluation in cirrhotics with esophageal varices. 59
Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studies 58
Efficacia di un trattamento diuretico organizzato per "steps" nella terapia dell'ascite in corso di cirrosi epatica. 58
La profilassi primaria dell'emorragia da rottura di varici esofagee 58
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 58
Effectiveness of a stepped care approach to diuretic treatment of ascites in cirrhotic patients 57
Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee 57
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 57
SPLENO-SYSTEMIC SHUNTS AND COVERT HEPATIC ENCEPHALOPATY 57
Identification of 5,6-trans-epoxyeicosatrienoic acid in the phospholipids of red blood cells 57
Diagnostic accuracy of AGILE 3+ score for advanced fibrosis in patients with NAFLD: A systematic review and meta-analysis 56
Effetti dell'Iloprost sull'emodinamica renale, sul metabolismo intrarenale del sodio e sul sistema renina-angiotensina-aldosterone. 56
Effect of nadolol on liver haemodynamics and function in patients with cirrhosis 56
L'eco-Doppler dei vasi splancnici nella cirrosi 56
Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study 56
Quantitative imaging by pixel-based contrast-enhanced ultrasound reveals a linear relationship between synovial vascular perfusion and the recruitment of pathogenic IL-17A-F+IL-23+ CD161+ CD4+ T helper cells in psoriatic arthritis joints 56
Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography 56
Interobserver and interequipment variability of hepatic, splenic, and renal arterial Doppler resistance indices in normal subjects and patients with cirhosis. J Hepatol 1997; 27: 986-992 (IF=4.974) 55
L'ipertensione portale 55
Effetto protettivo del corm-3 nei confronti del danno da ischemia-riperfusione in un modello sperimentale porcino 55
The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations 55
Heme oxygenase regulates the response of intrarenal arteries to alpha-adrenergic stimulation in experimental cirrhosis 55
Increased renal production of cytochrome P450-dependent metabolites of arachidonic acid in cyclosporine-induced nephrotoxicity 54
Early Diagnosis of Type-2 Cardio-renal Syndrome by Doppler Sonographic Evaluation of Renal Vasoconstriction 54
Myocardial overexpression of ANKRD1 causes sinus venosus defects and progressive diastolic dysfunction 54
Interobserver and inter-equipment variability of echo-Doppler evaluation of the superior mesenteric artery 54
PGE2 renali e metabolismo del sodio e dell'acqua nella cirrosi epatica anascitica 53
Impaired sodium and water excretion in preascitic cirrhosis: renal mechanisms. 53
Splanchnic hemodynamics in portal hypertension 53
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 53
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) ON NON-OBESE DIABETES: PREVALENCE AND RELATIONSHIP WITH DOPPLER HEMODINAMIC ALTERATIONS, LEPTIN, INFLAMMATION AND OXIDATIVE STRESS 53
Indici di volume ematico centrale nella cirrosi epatica in fase ascitica. 52
Renal effects of nadolol in patients with liver cirrhosis 52
Role of HO/CO in the Control of Peripheral Circulation in Humans 52
Blood flow of experimental liver metastases in rat as evaluated by the locally injected 133-Xenon washout 52
null 52
Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats with ascites 52
Clinical significance of data obtained from hepatic vein catheterization in the prognostic evaluation of patients with cirrhosis with esophageal varices. 51
Totale 6.671
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.341
article - articoli 58.171
book - libri 743
conference - conferenze 11.799
curatela - curatele 0
other - altro 397
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.231
Totale 148.682
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.445 0 0 60 344 264 295 23 9 12 8 332 98
2021/20221.598 104 209 11 23 111 21 54 116 108 116 238 487
2022/20232.483 283 156 347 236 379 701 15 101 162 10 49 44
2023/20241.224 52 86 86 113 70 198 129 77 2 63 251 97
2024/20254.564 298 280 183 803 163 51 110 480 523 244 361 1.068
2025/20262.141 1.149 687 305 0 0 0 0 0 0 0 0 0
Totale 14.647